| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30087724 | HIV | ENSG00000108878.5 | protein_coding | CACNG1 | No | No | 786 | Q06432 |
| TVIS30044813 | HIV | ENSG00000108878.5 | protein_coding | CACNG1 | No | No | 786 | Q06432 |
| TVIS20036507 | HPV | ENSG00000108878.5 | protein_coding | CACNG1 | No | No | 786 | Q06432 |
| TVIS44023880 | HTLV-1 | ENSG00000108878.5 | protein_coding | CACNG1 | No | No | 786 | Q06432 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CACNG1 |
|---|---|
| DrugBank ID | DB04842 |
| Drug Name | Fluspirilene |
| Target ID | BE0000679 |
| UniProt ID | Q06432 |
| Regulation Type | inhibitor |
| PubMed IDs | 1696149; 11842444 |
| Citations | Kenny BA, Fraser S, Kilpatrick AT, Spedding M: Selective antagonism of calcium channel activators by fluspirilene. Br J Pharmacol. 1990 Jun;100(2):211-6.@@Wang SJ: Inhibition of glutamate release by fluspirilene in cerebrocortical nerve terminals (synaptosomes). Synapse. 2002 Apr;44(1):36-41. |
| Groups | Approved; Investigational |
| Direct Classification | Diphenylmethanes |
| SMILES | FC1=CC=C(C=C1)C(CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1)C1=CC=C(F)C=C1 |
| Pathways | |
| PharmGKB | PA162565878 |
| ChEMBL | CHEMBL46516 |
